Dobutamine/milrinoneLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1949卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36159-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：179 / 179

相关论文

共 50 条

[21] Esmolol/milrinoneLack of efficacy: case report
Reactions Weekly, 2020, 1827 (1) : 142 - 142
[22] Furosemide/milrinoneLack of efficacy: case report
Reactions Weekly, 2021, 1839 (1) : 145 - 145
[23] Epoprostenol/milrinoneLack of efficacy: case report
Reactions Weekly, 2025, 2050 (1) : 226 - 226
[24] Epinephrine/MilrinoneLack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 181 - 181
[25] Epoprostenol/milrinoneLack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 240 - 240
[26] Epinephrine/milrinoneLack of efficacy: case report
Reactions Weekly, 2020, 1822 (1) : 131 - 131
[27] Digoxin/milrinoneLack of efficacy: case report
Reactions Weekly, 2021, 1883 (1) : 154 - 154
[28] Bivalirudin/furosemide/milrinoneLack of efficacy : case report
Reactions Weekly, 2024, 2018 (1) : 91 - 91
[29] Norepinephrine, vasopressin and milrinoneLack of efficacy: case report
Reactions Weekly, 2021, 1856 (1) : 324 - 324
[30] Amiodarone/epinephrine/milrinoneLack of efficacy: case report
Reactions Weekly, 2022, 1895 (1) : 29 - 29

← 1 2 3 4 5 →